St Clair M - Search Results

1

Antiviral efficacy of abacavir in antiretroviral therapy-experienced adults harbouring HIV-1 with specific patterns of resistance to nucleoside reverse transcriptase inhibitors.

Lanier ER, Ait-Khaled M, Scott J, Stone C, Melby T, Sturge G, St Clair M, Steel H, Hetherington S, Pearce G, Spreen W, Lafon S. Lanier ER, et al. Among authors: st clair m. Antivir Ther. 2004 Feb;9(1):37-45. doi: 10.1177/135965350400900102. Antivir Ther. 2004. PMID: 15040535

2

Effect of concurrent zidovudine use on the resistance pathway selected by abacavir-containing regimens.

Lanier ER, Givens N, Stone C, Griffin P, Gibb D, Walker S, Tisdale M, Irlbeck D, Underwood M, St Clair M, Ait-Khaled M. Lanier ER, et al. Among authors: st clair m. HIV Med. 2004 Nov;5(6):394-9. doi: 10.1111/j.1468-1293.2004.00243.x. HIV Med. 2004. PMID: 15544690 Free article.

3

Nucleoside and nucleotide analogue reverse transcriptase inhibitors: a clinical review of antiretroviral resistance.

Gallant JE, Gerondelis PZ, Wainberg MA, Shulman NS, Haubrich RH, St Clair M, Lanier ER, Hellmann NS, Richman DD. Gallant JE, et al. Among authors: st clair m. Antivir Ther. 2003 Dec;8(6):489-506. Antivir Ther. 2003. PMID: 14760883 Review.

4

Deletions in the beta3-beta4 hairpin loop of HIV-1 reverse transcriptase are observed in HIV-1 isolated from subjects during long-term antiretroviral therapy.

Ross L, Johnson M, Ferris RG, Short SA, Boone LR, Melby TE, Lanier R, Shaefer M, St Clair M. Ross L, et al. Among authors: st clair m. J Hum Virol. 2000 May-Jun;3(3):144-9. J Hum Virol. 2000. PMID: 10881994

5

Pharmacokinetics, safety, and monotherapy antiviral activity of GSK1265744, an HIV integrase strand transfer inhibitor.

Spreen W, Min S, Ford SL, Chen S, Lou Y, Bomar M, St Clair M, Piscitelli S, Fujiwara T. Spreen W, et al. Among authors: st clair m. HIV Clin Trials. 2013 Sep-Oct;14(5):192-203. doi: 10.1310/hct1405-192. HIV Clin Trials. 2013. PMID: 24144896 Clinical Trial.

6

Differential impact of thymidine analogue mutations on emtricitabine and lamivudine susceptibility.

Ross LL, Parkin N, Gerondelis P, Chappey C, Underwood MR, St Clair MH, Lanier ER. Ross LL, et al. J Acquir Immune Defic Syndr. 2006 Dec 15;43(5):567-70. doi: 10.1097/01.qai.0000243123.90400.62. J Acquir Immune Defic Syndr. 2006. PMID: 17075395

7

Sensitivity of phenotypic susceptibility analyses for nonthymidine nucleoside analogues conferred by K65R or M184V in mixtures with wild-type HIV-1.

Underwood MR, Ross LL, Irlbeck DM, Gerondelis P, Rouse E, St Clair MH, Trinh L, Parkin N, Lanier E. Underwood MR, et al. Among authors: st clair mh. J Infect Dis. 2009 Jan 1;199(1):84-8. doi: 10.1086/595296. J Infect Dis. 2009. PMID: 19032103

8

Prevalence of pretreatment and acquired HIV-1 mutations associated with resistance to lamivudine or rilpivirine: a systematic review.

Vannappagari V, Ragone L, Henegar C, van Wyk J, Brown D, Demarest J, Quercia R, St Clair M, Underwood M, Gatell JM, de Ruiter A, Aboud M. Vannappagari V, et al. Among authors: st clair m. Antivir Ther. 2019;24(6):393-404. doi: 10.3851/IMP3331. Antivir Ther. 2019. PMID: 31503008

9

Long-acting cabotegravir plus rilpivirine for treatment in adults with HIV-1 infection: 96-week results of the randomised, open-label, phase 3 FLAIR study.

Orkin C, Oka S, Philibert P, Brinson C, Bassa A, Gusev D, Degen O, García JG, Morell EB, Tan DHS, D'Amico R, Dorey D, Griffith S, Thiagarajah S, St Clair M, Van Solingen-Ristea R, Crauwels H, Ford SL, Patel P, Chounta V, Vanveggel S, Cutrell A, Van Eygen V, Vandermeulen K, Margolis DA, Smith KY, Spreen WR. Orkin C, et al. Among authors: st clair m. Lancet HIV. 2021 Apr;8(4):e185-e196. doi: 10.1016/S2352-3018(20)30340-4. Lancet HIV. 2021. PMID: 33794181 Clinical Trial.

10

Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection.

Orkin C, Arasteh K, Górgolas Hernández-Mora M, Pokrovsky V, Overton ET, Girard PM, Oka S, Walmsley S, Bettacchi C, Brinson C, Philibert P, Lombaard J, St Clair M, Crauwels H, Ford SL, Patel P, Chounta V, D'Amico R, Vanveggel S, Dorey D, Cutrell A, Griffith S, Margolis DA, Williams PE, Parys W, Smith KY, Spreen WR. Orkin C, et al. Among authors: st clair m. N Engl J Med. 2020 Mar 19;382(12):1124-1135. doi: 10.1056/NEJMoa1909512. Epub 2020 Mar 4. N Engl J Med. 2020. PMID: 32130806 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

180 results

Search Page

Filters